Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Mozo, Ana Noblejas
24  Ergebnisse:
Personensuche X
?
1

Red flags for clinical suspicion of eosinophilic granulomat..:

Solans-Laqué, R. ; Rúa-Figueroa, I. ; Blanco Aparicio, M....
European Journal of Internal Medicine.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

The utility of 18F-FDG-PET/CT in detecting extracranial lar..:

González-García, Andrés ; Fabregate, Martín ; Serralta, Gonzalo...
Revista Clínica Española (English Edition).  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Utilidad del 18F-FDG-PET/TC en la detección de vasculitis d..:

González-García, A. ; Fabregate, M. ; Serralta, G....
Revista Clínica Española.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMU..:

Maria Ribera, Josep ; Morgades, Mireia ; García-Calduch, Olga...
HemaSphere.  7 (2023)  S3 - p. e813564b , 2023
Link: https://doi.org/10.1097/..
 
?
5

Feasibility and outcomes after dose reduction of immunochem..:

Ribera, Josep-Maria ; Morgades, Mireia ; Garcia-Calduch, Olga...
Haematologica.  109 (2023)  2 - p. 543-552 , 2023
Link: https://doi.org/10.3324/..
 
?
6

TACkling Cancer by Targeting Selective Protein Degradation:

Noblejas-López, María del Mar ; Tébar-García, David ; López-Rosa, Raquel...
Pharmaceutics.  15 (2023)  10 - p. 2442 , 2023
Link: https://doi.org/10.3390/..
 
?
7

Macitentan for the Treatment of Refractory Digital Ulcers i..:

Soto Abánades, Clara ; Noblejas Mozo, Ana ; Bonilla Hernán, Gema..
Cureus.  , 2023
Link: https://doi.org/10.7759/..
 
?
8

Biological sequential therapy with rituximab-belimumab in p..:

Robles-Marhuenda, Angel ; Cobo-Ibáñez, Tatiana ; Noblejas-Mozo, Ana.
Reumatología Clínica (English Edition).  19 (2023)  5 - p. 290-291 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Cardiac involvement in a Spanish unicentric prospective coh..:

Álvarez Troncoso, Jorge ; Soto Abanades, Clara ; Robles Marhuenda, Ángel...
Lupus.  32 (2022)  1 - p. 111-118 , 2022
Link: https://doi.org/10.1177/..
 
?
10

Posterior Reversible Encephalopathy (PRES) as a Presentatio..:

Troncoso, Jorge Álvarez ; Ballester, Laura Lacruz ; Mozo, Ana Noblejas...
Journal of Clinical Rheumatology and Immunology.  22 (2022)  2 - p. 73-77 , 2022
Link: https://doi.org/10.1142/..
 
?
11

Posterior Reversible Encephalopathy (PRES) as a Presentatio..:

Jorge Álvarez Troncoso ; Laura Lacruz Ballester ; Ana Noblejas Mozo...
https://www.worldscientific.com/doi/10.1142/S266134172272004X.  , 2022
Link: https://doi.org/10.1142/..
 
?
12

Mapping of Genomic Vulnerabilities in the Post-Translationa..:

Fuentes-Antrás, Jesús ; Alcaraz-Sanabria, Ana Lucía ; Morafraile, Esther Cabañas...
Cancers.  13 (2021)  4 - p. 833 , 2021
Link: https://doi.org/10.3390/..
 
?
13

Potential of hazard mapping as a tool for facing COVID-19 t..:

Perles Roselló, María Jesús ; Sortino Barrionuevo, Juan Francisco ; Cantarero Prados, Francisco José...
Boletín de la Asociación de Geógrafos Españoles.  , 2021
Link: https://doi.org/10.21138..
 
?
14

Outcome of Second Allogeneic Hematopoietic Cell Transplanta..:

Orti, Guillermo ; Sanz, Jaime ; Bermudez, Arancha...
Biology of Blood and Marrow Transplantation.  22 (2016)  3 - p. 584-588 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Enumeration of NKG2C+natural killer cells early following a..:

Giménez, Estela ; Solano, Carlos ; Amat, Paula...
Journal of Medical Virology.  87 (2015)  9 - p. 1601-1607 , 2015
Link: https://doi.org/10.1002/..
 
1-15